1. Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin. Nature 1997; 387: 861.
2. Cole GW, Silverberg NL. The adherence of Staphylococcus aureus to human comeocytes. Arch Dermatol 1986; 122: 166–9.
3. Chiller К, Selkin B, Murakawa G. Skin Microflora and Bacterial Infections of the Skin. J Investigative Dermatol Symposium Proceedings 2001; 6: 170–4.
4. Wilkinson JD. Fusidic acid in dermatology. Br J Dermatol 1998; 139: 37–40.
5. Anthony C. Antibacterial/steroid combination therapy in infected eczema. Acta Derm Venereol 2008; Suppl. 216: 28–34.
6. Leung DYM. The role Staphylococcus aureus in atopic eczema. Acta Derm Venereol 2008; Suppl. 216: 21–7.
7. Rigopoulos D, Larios G. Fucidic acid: a valuable agent for controlling Staphylococcus aureus skin infections. Acta Derm Venereol 2008; Suppl. 216: 7–13.
8. Long BH. Fucidic acid in skin and soft-tissue infections. Acta Derm Venereol 2008; Suppl. 216: 14–20.
9. Stuttgen G, Bauer E. Pentration and Pemeation into Human Skin of Fusidic Acid in Different Galenical Formulation. Arzneum.-Forsch. Drug Res1988; 38 (1, 5): 703–35.
10. Morris SD, Rycroft RJ, White IR et al. Comparative frequency of patch test reactions to topical antibiotics. Br J Dermatol 2002; 146: 1047–51.
Авторы
Е.В.Дворянкова, И.М.Соркина, Н.В.Каратаева, И.М.Корсунская
Центр теоретических проблем физико-химической фармакологии РАН;
Городская клиническая больница №14 им. В.Г.Короленко